Options
Heraclides, Alexandros
Loading...
Preferred name
Heraclides, Alexandros
Translated Name
Ηρακλείδης, Αλέξανδρος
Position
Associate Professor
Main Affiliation
School
Department
Scopus Author ID
24066844700
Google Scholar ID
Um57zgAAAAJ
1 results
Now showing 1 - 1 of 1
- PublicationLack of association between vaccination rates and excess mortality in Cyprus during the COVID-19 pandemic(Elsevier Ltd, 2023)
; ; ;Maria Athanasiadou ;Anna Demetriou ;Despina StylianouOlga KalakoutaBackground: It has been claimed that COVID-19 vaccination is associated with excess mortality during the COVID-19 pandemic, a claim that contributes to vaccine hesitancy. We examined whether all-cause mortality has actually increased in Cyprus during the first two pandemic years, and whether any increases are associated with vaccination rates. Methods: We calculated weekly excess mortality for Cyprus between January 2020 and June 2022, overall and by age group, using both a Distributed Lag Nonlinear Model (DLNM) adjusted for mean daily temperature, and the EuroMOMO algorithm. Excess deaths were regressed on the weekly number of confirmed COVID-19 deaths and on weekly first-dose vaccinations, also using a DLNM to explore the lag-response dimension. Results: 552 excess deaths were observed in Cyprus during the study period (95% CI: 508–597) as opposed to 1306 confirmed COVID-19 deaths. No association between excess deaths and vaccination rates was found overall and for any age group except 18–49 years, among whom 1.09 excess deaths (95% CI: 0.27–1.91) per 10,000 vaccinations were estimated during the first 8 weeks post-vaccination. However, detailed cause-of-death examination identified just two such deaths potentially linked to vaccination, therefore this association is spurious and attributable to random error. Conclusions: Excess mortality was moderately increased in Cyprus during the COVID-19 pandemic, primarily as a result of laboratory-confirmed COVID-19 deaths. No relationship was found between vaccination rates and all-cause mortality, demonstrating the excellent safety profile of COVID-19 vaccines.